technetium tc 99m hydroxymethylene diphosphonate and Biliary Cirrhosis

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Biliary Cirrhosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M	1

Trials

1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Biliary Cirrhosis

Article	Year
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology, 1997, Volume: 113, Issue:1 Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidronic Acid; Female; Femur; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Lumbar Vertebrae; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Time Factors	1997

Article

Year

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.

Gastroenterology, 1997, Volume: 113, Issue:1

Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidronic Acid; Female; Femur; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Lumbar Vertebrae; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Time Factors

1997